GO:0044381 glucose import in response to insulin stimulus

Glucose import in response to insulin stimulus (GO:0044381) is a fundamental biological process that ensures postprandial glucose disposal into insulin-sensitive tissues. This term captures the directed movement of the hexose monosaccharide glucose into a cell as a direct result of an insulin stimulus. Unlike constitutive glucose uptake, this process is acutely regulated and is critical for maintaining systemic glucose homeostasis. Defects in this pathway are central to the pathogenesis of insulin resistance and type 2 diabetes, making it a prime target for therapeutic intervention and genetic research. The process is also relevant to broader physiological contexts, as genome-wide association studies have identified enrichment of insulin signaling and glucose transport gene sets in complex traits such as suicide behavior, suggesting metabolic dysregulation may contribute to neuropsychiatric phenotypes. Furthermore, mitochondrial dysfunction in pancreatic beta cells, as modeled by tissue-specific knockout mice, impairs insulin secretion and consequently reduces insulin-stimulated glucose import in target tissues, illustrating the interconnectedness of insulin production and action. Understanding the molecular players and regulatory mechanisms of GO:0044381 is therefore essential for researchers in metabolism, endocrinology, and neuroscience.

GO:0044381 is defined as the directed movement of the hexose monosaccharide glucose into a cell as a result of an insulin stimulus. In simpler terms, it is the insulin-triggered process by which glucose enters cells, primarily in muscle and fat tissues, to lower blood glucose levels after a meal. This process is synonymous with cellular glucose import in response to insulin stimulus and is a key component of insulin action.

GO:0044381 is critically important because it represents the primary mechanism by which insulin lowers blood glucose after a meal. Dysregulation of this process leads to insulin resistance, a hallmark of type 2 diabetes and metabolic syndrome. Understanding the genes and signaling cascades involved is essential for developing targeted therapies. Moreover, recent evidence links insulin signaling and glucose transport pathways to neuropsychiatric conditions such as suicide behavior, expanding the relevance of this term beyond classical metabolism. Mitochondrial dysfunction in beta cells can also impair insulin secretion, indirectly affecting glucose import in peripheral tissues, as shown in tissue-specific knockout models. Thus, GO:0044381 sits at the intersection of diabetes, obesity, and brain health research.

The following genes and proteins are central to the regulation and execution of glucose import in response to insulin stimulus.

The process of glucose import in response to insulin stimulus is tightly regulated at multiple levels. Positive regulation occurs through the insulin receptor tyrosine kinase, IRS1/2, PI3K, and AKT, which collectively promote GLUT4 translocation. Negative regulation is mediated by phosphatases such as PTEN, which dephosphorylates PIP3, and by protein tyrosine phosphatases like PTP1B that dephosphorylate the insulin receptor. Additionally, the mTOR pathway integrates nutrient signals and can feedback-inhibit insulin signaling via S6K1-mediated phosphorylation of IRS1. Mitochondrial function in pancreatic beta cells also regulates insulin secretion, thereby indirectly controlling the magnitude of the response in target tissues. Dysregulation of these regulatory loops contributes to insulin resistance and type 2 diabetes.

Impaired glucose import in response to insulin stimulus is a hallmark of type 2 diabetes. Defects in insulin signaling, GLUT4 translocation, or mitochondrial function in beta cells lead to reduced glucose uptake in muscle and fat, causing hyperglycemia. Tissue-specific knockout mice with mitochondrial dysfunction in beta cells exhibit impaired insulin secretion, which secondarily reduces insulin-stimulated glucose import in peripheral tissues. Understanding these mechanisms is critical for developing new therapies.

Obesity is strongly associated with insulin resistance in adipose tissue and skeletal muscle. Enlarged adipocytes exhibit impaired insulin-stimulated glucose transport, contributing to systemic metabolic dysfunction. Genetic and environmental factors that alter the expression or function of GLUT4, IRS1, or AKT2 can exacerbate this condition. Research into GO:0044381 provides insights into how obesity disrupts glucose homeostasis.

Recent systematic review and enrichment analysis of GWAS studies identified gene ontology terms and pathways implicated in suicide behavior, including insulin signaling and glucose transport. This suggests that dysregulated glucose import in response to insulin may contribute to neuropsychiatric phenotypes, possibly through effects on brain energy metabolism and neurotransmitter function. This emerging link highlights the need for further research using CRISPR models to dissect causality.

Mitochondrial dysfunction in pancreatic beta cells, as modeled by tissue-specific knockout mice, leads to impaired insulin secretion and beta-cell loss, resembling mitochondrial diabetes. This indirectly affects glucose import in response to insulin in target tissues due to insufficient insulin. The study of such models helps elucidate the interplay between mitochondrial function, insulin secretion, and peripheral glucose uptake.

Genome-wide CRISPR knockout or activation screens can identify novel regulators of glucose import in response to insulin. Cells are infected with lentiviral sgRNA libraries, selected under insulin-stimulated conditions, and sgRNA enrichment is analyzed by next-generation sequencing. This approach has been used to uncover genes involved in insulin signaling and GLUT4 trafficking.

RNA-seq and quantitative proteomics can reveal changes in gene and protein expression upon insulin stimulation or in disease models. For example, comparing wild-type and knockout cells can identify pathways co-regulated with glucose import. These methods help validate hits from screens and provide mechanistic insights.

Tagging GLUT4 with a fluorescent protein (e.g., GFP) using CRISPR knock-in allows real-time visualization of vesicle translocation to the plasma membrane in response to insulin. Total internal reflection fluorescence (TIRF) microscopy is particularly useful for studying fusion events at the cell surface.

Radiolabeled 2-deoxyglucose or fluorescent glucose analogs (e.g., 2-NBDG) are used to measure glucose uptake in cultured cells. These assays are rapid and quantitative, making them ideal for validating genetic perturbations. They are commonly used in combination with CRISPR models.

Researchers studying glucose import in response to insulin stimulus-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes identified from GWAS, transcriptomics, or screens. By leveraging knockout, point mutation, knock-in, and overexpression technologies, EDITGENE empowers scientists to dissect the molecular mechanisms of insulin-stimulated glucose uptake and its dysregulation in disease.

Glucose import in response to insulin stimulus (GO:0044381) is a cornerstone of metabolic homeostasis, with profound implications for diabetes, obesity, and emerging links to neuropsychiatric disorders. The pathway involves a complex interplay of receptors, kinases, and vesicle trafficking proteins, many of which have been validated using CRISPR-based models. Continued research using advanced genetic tools will unravel new therapeutic targets and deepen our understanding of insulin action. EDITGENE stands ready to support these efforts with tailored CRISPR solutions.